2023
DOI: 10.1155/2023/1744102
|View full text |Cite
|
Sign up to set email alerts
|

Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination

Abstract: Background. Pancreatic cancer is a highly aggressive malignancy worldwide with rapid development and an exceedingly poor prognosis. lncRNAs play crucial roles in regulating the biological behaviors of tumor cells. In this study, we discovered that LINC00578 acted as a regulator of ferroptosis in pancreatic cancer. Methods. A series of loss- and gain-of-function experiments in vitro and in vivo were performed to explore the oncogenic role of LINC00578 in pancreatic cancer development and progression. Label-free… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 34 publications
0
1
0
Order By: Relevance
“…GLRB is also considered as a potential drug target for colorectal cancer (64). LINC00578, a recently identified long noncoding RNA (lncRNA), has been linked to prognosis in lung, breast, and pancreatic cancers (65)(66)(67). Furthermore, research suggests that LINC00578 promotes the development and growth of pancreatic cancer by inhibiting ferroptosis, a type of cell death induced by iron-dependent oxidation (67).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…GLRB is also considered as a potential drug target for colorectal cancer (64). LINC00578, a recently identified long noncoding RNA (lncRNA), has been linked to prognosis in lung, breast, and pancreatic cancers (65)(66)(67). Furthermore, research suggests that LINC00578 promotes the development and growth of pancreatic cancer by inhibiting ferroptosis, a type of cell death induced by iron-dependent oxidation (67).…”
Section: Discussionmentioning
confidence: 99%
“…LINC00578, a recently identified long noncoding RNA (lncRNA), has been linked to prognosis in lung, breast, and pancreatic cancers (65)(66)(67). Furthermore, research suggests that LINC00578 promotes the development and growth of pancreatic cancer by inhibiting ferroptosis, a type of cell death induced by iron-dependent oxidation (67). Long intergenic non-protein coding RNA 968 (LINC00968) may function as an oncogene in certain cancers, such as osteosarcoma (68), while acting as a tumor suppressor in others, such as lung adenocarcinoma (69).…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, the deubiquitinating enzymes OTUB1 and ubiquitin specific peptidase 20 (USP20) mediate the deubiquitination of SLC7A11, thereby stabilizing SLC7A11 levels in cancer cells [ 6 , 122 ]. Additionally, hepatocellular carcinoma ferroptosis associative lncRNA (HEPFAL) accelerates ferroptosis in hepatocellular carcinoma cells, whereas lncRNA LINC00578 inhibits ferroptosis by modulating the ubiquitination of SLC7A11 in pancreatic cancer cells [ 123 , 124 ]. In contrast, fascin actin-bundling protein 1 (FSCN1) directly interacts with SLC7A11, enhancing its degradation by UPS in breast cancer cells [ 125 ].…”
Section: Protein Degradation In Ferroptosismentioning
confidence: 99%
“…Moreover, lncHEPFAL reduces SLC7A11 by promoting its ubiquitination and degradation, eventually enhancing erastin-induced ferroptosis in hepatocellular carcinoma [155]. On the other hand, lncRNA LINC00578 also inhibits SLC7A11 ubiquitination by binding to UBE2K to inhibit ferroptosis in pancreatic cancer [262]. CircBGN directly binds to OTUB1 and SLC7A11, enhancing OTUB1-mediated SLC7A11 deubiquitination to inhibit ferroptosis in breast cancer [263].…”
Section: Ncrnas Regulating Ferroptosis Through Antioxidant Defensementioning
confidence: 99%